SCHEMBL4612185

SCHEMBL4612185

[CH2]C(O)CNC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10523193 0.81
SCHEMBL7063746 0.77 CYP2D6 (0.48)
SCHEMBL22721124 0.77
SCHEMBL438765 0.74
SCHEMBL437044 0.74
SCHEMBL756930 0.74
SCHEMBL14027348 0.72 TSHR (0.46)
Hydrochloric Acid SCHEMBL10873242 0.72 LMNA (0.42)
SCHEMBL21392054 0.72
SCHEMBL21115026 0.70 LMNA (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4505923-A GLAUCOMA MERCK & CO., INC. (US) 1985-03-19 US claimed
EP-0008711-B1 A METHOD OF PREPARING A 2-HYDROXY-3-ISOPROPYL OR A 2-HYDROXY-3-TERT-BUTYLAMINOPROPYL AROMATIC ETHER SMITHKLINE BECKMAN CORPORATION (US) 1981-11-04 EP claimed
EP-0008711-A1 A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether SMITHKLINE BECKMAN CORPORATION (US) 1980-03-19 EP claimed
CN-108026067-A 6- amino-quinolin -3- nitriles as COT conditioning agents 吉利德科学公司 2018-05-11 CN disclosed
EP-1865016-B1 Organosilicon compounds comprising cyclodextrin radicals WACKER CHEMIE AG (DE) 2008-11-26 EP disclosed
EP-1530607-B1 ORGANOSILICON COMPOUNDS COMPRISING CYCLODEXTRIN RADICALS WACKER CHEMIE AG (DE) 2008-10-29 EP disclosed
EP-1865016-A1 Organosilicon compounds comprising cyclodextrin radicals Wacker Chemie AG (DE) 2007-12-12 EP disclosed
US-7235186-B2 Organosilicon compounds comprising cyclodextrin radicals WACKER CHEMIE AG (DE) 2007-06-26 US disclosed
US-20060009592-A1 Organosilicon compounds comprising cyclodextrin radicals WACKER-CHEMIE GMBH (DE) 2006-01-12 US disclosed
US-5476848-A Antihistamines SANKYO COMPANY, LIMITED (JP) 1995-12-19 US disclosed
US-5461051-A Tetracyclic compounds having anti-allergic and anti-asthmatic activities and their use SANKYO COMPANY, LIMITED (JP) 1995-10-24 US disclosed
US-5362725-A Antiallergens, antiasthmatic SANKYO COMPANY, LIMITED (JP) 1994-11-08 US disclosed
EP-0505014-A2 Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use Sankyo Company Limited (JP) 1992-09-23 EP disclosed
EP-0421823-A2 Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use Sankyo Company Limited (JP) 1991-04-10 EP disclosed
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 EP disclosed
EP-0008711-A1 A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether SMITHKLINE BECKMAN CORPORATION (US) 1980-03-19 EP disclosed